Xcout IntelCureGenetics competitors & alternatives
The 12 closest competitors and alternatives to CureGenetics among healthcare companies — ranked by similarity to what CureGenetics actually does, not by market-cap band.
Subscribe to see CureGenetics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About CureGenetics
CureGenetics is a biotechnology company headquartered in Suzhou, China, focused on the development of gene and cutting-edge medical therapies.
CureGenetics at a glance
CureGenetics is a healthcare company headquartered in China. Its most recent funding round, Series A, raised $17M in August 2018. Xcout tracks 6 named people at CureGenetics, including Dr. Yuanyuan Xu (Chairman & CEO).
CureGenetics leadership
- Dr. Yuanyuan XuChairman & CEO
- Dr. Shawn HeChief Scientific Officer
- Dr. Yanni LinCo-founder & Chief Scientist
- Grace HeSVP，Head of Clinical Development
- Dr. Lin ZhuVP, Head of Preclinical Development
- Dr. Lei ZhaoED, Head of AAV Discovery
CureGenetics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $17M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 CureGenetics competitors
Ranked by semantic similarity — how close each company is to CureGenetics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar healthcare company
Belief BioMed Inc. is a globally innovative biotechnology company that integrates the development, manufacturing, and clinical application of gene therapy products. The company operates research centers, manufacturing facilities, and offices across multiple cities in China as well as the United States. Its primary operations are rooted in Shanghai, China.
Similar healthcare company
GEn1E Lifesciences Inc. is a clinical-stage, Phase 2 biotechnology research company based in Palo Alto, California, focused on accelerating novel precision therapies.
Similar healthcare company
GenEdit is a South San Francisco, California-based startup developing alternative methods of delivering gene-based and CRISPR-based medicines.
Biotechnology
EdiGene is a clinical-stage biotechnology company founded in 2015 that focuses on translating gene-editing technologies into therapeutic products. Headquartered in Beijing, China, the company also operates research and office facilities in locations such as Shanghai, Guangzhou, and the United States.
Biotechnology
KiraGen Bio is a Boston-based biotechnology company pioneering the development of AI-driven, multiplex gene-edited CAR-T cell therapies designed to target and block tumor suppression.
Biotechnology
Yaotang (Shanghai) Biotechnology Co., Ltd. is a high-tech biotechnology company focused on developing mRNA drugs and gene editing treatments. The company combines in vivo mRNA delivery technology with gene editing to target hereditary and cardiovascular diseases.
Biotechnology
Beijing GeneCradle Technology Co., Ltd. is a Chinese biotechnology and pharmaceutical discovery company focused on gene therapy solutions such as GC304 injection.
Biotechnology
NutrigeneAI Biotech Limited is an iPSC cell therapy platform operating in Hong Kong. The company focuses on biotechnology research and development, maintaining pipeline therapies and regional office operations.
Biotechnology
YolTech Therapeutics is a clinical-stage biotech company founded in 2021 that specializes in creating in vivo gene editing medicines and mRNA drugs to treat serious diseases. Based in China, the company is advancing a pipeline of CRISPR therapies designed for one-time treatment.
Therapeutics
eGenesis, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, focused on developing advanced genome-editing solutions. The company utilizes its proprietary platform to work on xenotransplantation and address organ shortages for human patients.
Biotechnology
Carmine Therapeutics, Inc. is an EVX Ventures company headquartered in Cambridge, Massachusetts, focused on developing novel gene therapies.
Biotechnology
Canary Cure Therapeutics is a privately held biopharmaceutical company headquartered in Burlington, Canada. It focuses on developing novel gene and RNA therapies to address various medical needs. The company operates with a small team and maintains its primary operations in Ontario.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of CureGenetics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for CureGeneticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →